Who
Chaime Orlev
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Kamada; CFO, Treasurer and Secretary, Oramed Pharmaceuticals; CFO of GammaCan Int'l, Inc., Gammacan International.
In numbers
- Trades disclosed
- 47
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 6 Oct 2005
- Last trade
- 27 Aug 2026
- Last filed
- 23 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Aug 2026filed 23 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 27 Aug 2026filed 23 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 27 Aug 2026filed 23 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 27 Aug 2026filed 23 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 27 Aug 2026filed 23 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 27 Aug 2026filed 23 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,500 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.